DNB Asset Management AS Has $1.71 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

DNB Asset Management AS boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 18.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 26,731 shares of the company’s stock after buying an additional 4,176 shares during the quarter. DNB Asset Management AS’s holdings in Henry Schein were worth $1,713,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. KBC Group NV grew its holdings in Henry Schein by 163.5% during the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock worth $39,518,000 after acquiring an additional 323,901 shares during the period. Duality Advisers LP bought a new stake in Henry Schein in the fourth quarter valued at about $1,561,000. Everett Harris & Co. CA lifted its stake in Henry Schein by 13.9% in the first quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock valued at $9,006,000 after buying an additional 14,580 shares during the period. UniSuper Management Pty Ltd boosted its holdings in Henry Schein by 611.8% during the first quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after buying an additional 11,771 shares during the last quarter. Finally, Sprucegrove Investment Management Ltd. boosted its holdings in Henry Schein by 14.2% during the fourth quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after buying an additional 27,500 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HSIC has been the topic of a number of analyst reports. UBS Group cut their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Evercore ISI decreased their price target on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a report on Tuesday, July 9th. Robert W. Baird upgraded shares of Henry Schein from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $81.00 to $92.00 in a research report on Monday, July 22nd. Finally, Barrington Research reiterated an “outperform” rating and set a $92.00 target price on shares of Henry Schein in a report on Friday, July 5th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $81.67.

View Our Latest Report on HSIC

Henry Schein Trading Up 4.4 %

Shares of Henry Schein stock opened at $66.76 on Wednesday. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The business’s 50 day moving average is $67.84 and its 200-day moving average is $71.68. The stock has a market cap of $8.55 billion, a P/E ratio of 21.59, a P/E/G ratio of 1.80 and a beta of 0.87.

Henry Schein (NASDAQ:HSICGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The business’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.31 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post 5.16 earnings per share for the current fiscal year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.